NCT01598740View on ClinicalTrials.gov

Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Heart Failure
Interventions
DRUG

CLP

Oral administration

DRUG

Spironolactone

oral administration

Trial Locations (1)

92780

Orange Country Research Center, Tustin

Sponsors
All Listed Sponsors
lead

Sorbent Therapeutics

INDUSTRY